{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:47Z","timestamp":1786993727515,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,12]],"date-time":"2023-07-12T00:00:00Z","timestamp":1689120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA 82723"],"award-info":[{"award-number":["CA 82723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Liver Research"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.livres.2023.07.003","type":"journal-article","created":{"date-parts":[[2023,7,16]],"date-time":"2023-07-16T17:16:47Z","timestamp":1689527807000},"page":"256-262","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6111-5077","authenticated-orcid":false,"given":"Brian I.","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7827-1909","authenticated-orcid":false,"given":"Vito","family":"Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2395-3985","authenticated-orcid":false,"given":"Burak","family":"Isik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sezai","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.livres.2023.07.003_bib1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1002\/1097-0142(19850815)56:4<918::AID-CNCR2820560437>3.0.CO;2-E","article-title":"Natural history of hepatocellular carcinoma and prognosis in relation to treatment. Study of 850 patients","volume":"56","author":"Ouida","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/j.livres.2023.07.003_bib2","first-page":"33","article-title":"A\u00a0review of hepatocellular carcinoma (HCC) staging systems","volume":"2","author":"Subramanian","year":"2013","journal-title":"Chin Clin Oncol"},{"key":"10.1016\/j.livres.2023.07.003_bib3","first-page":"178","article-title":"A\u00a0liver index and its relationship to indices of HCC aggressiveness","volume":"5","author":"Carr","year":"2016","journal-title":"J\u00a0Integr Oncol"},{"key":"10.1016\/j.livres.2023.07.003_bib4","doi-asserted-by":"crossref","first-page":"641","DOI":"10.3390\/cancers12030641","article-title":"Inflammatory mechanisms of HCC development","volume":"12","author":"Refolo","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2023.07.003_bib5","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1007\/s12029-017-9971-4","article-title":"Validation of a liver index and its significance for HCC aggressiveness","volume":"48","author":"Carr","year":"2017","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.livres.2023.07.003_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.3390\/cancers13040592","article-title":"Identification of clinical phenotypes and related survival in patients with large HCCs","volume":"13","author":"Carr","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2023.07.003_bib7","first-page":"1953","article-title":"Identification of 2 large size HCC phenotypes, with and without associated inflammation","volume":"19","author":"Carr","year":"2022","journal-title":"Clin Pract"},{"key":"10.1016\/j.livres.2023.07.003_bib8","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/hep.25814","article-title":"Alpha-fetoprotein has no prognostic role in small hepatocellular carcinoma identified during surveillance in compensated cirrhosis","volume":"56","author":"Giannini","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.livres.2023.07.003_bib9","doi-asserted-by":"crossref","first-page":"413","DOI":"10.2147\/JHC.S272762","article-title":"Serum tumor markers for early diagnosis of primary hepatocellular carcinoma","volume":"7","author":"Zong","year":"2020","journal-title":"J\u00a0Hepatocell Carcinoma"},{"key":"10.1016\/j.livres.2023.07.003_bib10","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1245\/s10434-007-9730-z","article-title":"Biology of hepatocellular carcinoma","volume":"15","author":"Pang","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.livres.2023.07.003_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s12029-020-00424-w","article-title":"Liver transplantation for hepatocellular carcinoma: malatya experience and proposals for expanded criteria","volume":"51","author":"Ince","year":"2020","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.livres.2023.07.003_bib12","doi-asserted-by":"crossref","first-page":"5976","DOI":"10.3390\/cancers13235976","article-title":"Pre-transplant alpha-fetoprotein > 25.5 and its dynamic on waitlist are predictors of HCC recurrence after liver transplantation for patients meeting Milan criteria","volume":"13","author":"Magro","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.livres.2023.07.003_bib13","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/3120185","article-title":"Macroscopic portal vein thrombosis in HCC patients","volume":"2018","author":"Akkiz","year":"2018","journal-title":"Can J Gastroenterol Hepatol"},{"key":"10.1016\/j.livres.2023.07.003_bib14","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.3748\/wjg.v20.i8.2098","article-title":"Cancer stem cell markers correlate with early recurrence and survival in hepatocellular carcinoma","volume":"20","author":"Guo","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.livres.2023.07.003_bib15","doi-asserted-by":"crossref","first-page":"3882","DOI":"10.1245\/s10434-014-3779-2","article-title":"Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma","volume":"21","author":"Yamada","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.livres.2023.07.003_bib16","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1111\/hepr.12201","article-title":"Diagnostic accuracy of des-gamma-carboxy prothrombin versus \u03b1-fetoprotein for hepatocellular carcinoma: a systematic review","volume":"44","author":"Li","year":"2014","journal-title":"Hepatol Res"},{"key":"10.1016\/j.livres.2023.07.003_bib17","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1007\/s10620-007-9750-3","article-title":"Causes of death in patients with unresectable hepatocellular carcinoma","volume":"52","author":"Couto","year":"2007","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.livres.2023.07.003_bib18","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1007\/s00432-020-03331-6","article-title":"Effects of alpha-fetoprotein on the occurrence and progression of hepatocellular carcinoma","volume":"146","author":"Zheng","year":"2020","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.livres.2023.07.003_bib19","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1053\/j.gastro.2008.12.004","article-title":"EpCAM-positive hepatocellular carcinoma cells are tumor-initiating cells with stem\/progenitor cell features","volume":"136","author":"Yamashita","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.livres.2023.07.003_bib20","doi-asserted-by":"crossref","first-page":"7663","DOI":"10.18632\/oncotarget.2288","article-title":"CLDN3 inhibits cancer aggressiveness via Wnt-EMT signaling and is a potential prognostic biomarker for hepatocellular carcinoma","volume":"5","author":"Jiang","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.livres.2023.07.003_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/s12029-021-00801-z","article-title":"EMT and inflammation: crossroads in HCC","volume":"54","author":"Sengez","year":"2023","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.livres.2023.07.003_bib22","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1007\/s12029-020-00530-9","article-title":"Trends in tumor indices in relation to increased hepatocellular carcinoma size: evidence for tumor evolution as a function of growth","volume":"51","author":"Carr","year":"2020","journal-title":"J\u00a0Gastrointest Cancer"},{"key":"10.1016\/j.livres.2023.07.003_bib23","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/1724600821996372","article-title":"Changes in hepatocellular carcinoma aggressiveness characteristics with an increase in tumor diameter","volume":"36","author":"Carr","year":"2021","journal-title":"Int J Biol Markers"}],"container-title":["Liver Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000387?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2542568423000387?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T14:46:30Z","timestamp":1762872390000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2542568423000387"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2542568423000387"],"URL":"https:\/\/doi.org\/10.1016\/j.livres.2023.07.003","relation":{},"ISSN":["2542-5684"],"issn-type":[{"value":"2542-5684","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discordance among aggressiveness characteristics of hepatocellular carcinoma: Portal vein thrombosis and multifocality, related to tumor size, but not to serum alpha-fetoprotein level","name":"articletitle","label":"Article Title"},{"value":"Liver Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.livres.2023.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Third Affiliated Hospital of Sun Yat-sen University. Publishing services by Elsevier B. V. on behalf of KeAi Communications Co., Ltd.","name":"copyright","label":"Copyright"}]}}